Measles & Rubella Weekly Monitoring Report: October 12 to October 18, 2014 (week 42)

Key Points

  • In Canada, no new cases of measles were reported during week 42.
  • Measles activity remains high in the PhilippinesFootnote 1.

Organization: Public Health Agency of Canada

Date published: 2014-11-26

Related Topics

On this page

Epidemiological Summary

Figure 1. Number of cases measles (n=127) and rubella (n=1), by week of rash onset, as reported to the Canadian Measles/ Rubella Surveillance System (CMRSS) and Measles and Rubella Surveillance system (MARS), for the period ending October 18, 2014. Among these, rash onset is not currently available for 25 cases; they have been excluded from the figure but included in the year-to-date total below.

Figure 1
Figure 1 - Text Description
Figure 1. Number of cases measles (n=127) and rubella (n=1), by week of rash onset, as reported to the Canadian Measles/ Rubella Surveillance System (CMRSS) and Measles and Rubella Surveillance system (MARS), for the period ending October 18, 2014.
Epidemiological Week of Rash Onset, 2014 Number of confirmed measles cases reported Number of confirmed rubella cases reported
1 1 0
2 1 0
3 5 0
4 7 0
5 2 0
6 4 0
7 1 0
8 0 0
9 2 0
10 2 1
11 4 0
12 4 0
13 11 0
14 7 0
15 8 0
16 4 0
17 13 0
18 3 0
19 2 0
20 1 0
21 5 0
22 5 0
23 1 0
24 3 0
25 1 0
26 1 0
27 0 0
28 0 0
29 0 0
30 0 0
31 1 0
32 1 0
33 0 0
34 0 0
35 1 0
36 1 0
37 0 0
38 0 0
39 0 0
40 0 0
41 0 0
42 0 0
43 0 0
44 0 0
45 0 0
46 0 0
47 0 0
48 0 0
49 0 0
50 0 0
51 0 0
52 0 0
Missing Rash Onset 25 0
Cases (year-to-date) 127 1


During epidemiological week 42, 2014, no new cases of measles were reported in Canada.

The year-to-date totalFootnote 2 is 127 cases of measles and 1 case of rubella for 2014.

Geographic Distribution

Figure 2: Distribution of confirmed measles and rubella cases by health region. Cases are included if they are considereFigure 2d active.Figure 2 - Footnote *


Figure 2: Distribution of confirmed measles and rubella cases by health region. Cases are included if they are considered activeTable Figure 2 - Footnote *.
Health Region Measles Cases Rubella Cases
Eastern Regional Integrated Health Authority 0 0
Central Regional Integrated Health Authority 0 0
Western Regional Integrated Health Authority 0 0
Labrador-Grenfell Regional Integrated Health Authority 0 0
Prince Edward Island 0 0
South Shore District Health Authority 0 0
South West Nova District Health Authority 0 0
Annapolis Valley District Health Authority 0 0
Colchester East Hants Health Authority 0 0
Cumberland Health Authority 0 0
Pictou County Health Authority 0 0
Guysborough Antigonish Strait Health Authority 0 0
Cape Breton District Health Authority 0 0
Capital District Health Authority 0 0
Zone 1 (NB) 0 0
Zone 2 (NB) 0 0
Zone 3 (NB) 0 0
Zone 4 (NB) 0 0
Zone 5 (NB) 0 0
Zone 6 (NB) 0 0
Zone 7 (NB) 0 0
Québec et Chaudières-Appalaches 0 0
Centre-du-Québec 0 0
Montréal et Laval 0 0
Ouest-du-Québec 0 0
Montérégie 0 0
Nord-Est 0 0
Ontario Central East 0 0
Ontario Central West 0 0
Ontario Eastern 0 0
Ontario North East 0 0
Ontario North West 0 0
Ontario South West 0 0
City of Toronto Health Unit 0 0
Winnipeg Regional Health Authority 0 0
Prairie Mountain Health 0 0
Interlake-Eastern Regional Health Authority 0 0
Northern Regional Health Authority 0 0
Southern Health 0 0
Saskatchewan South 0 0
Saskatchewan Central 0 0
Saskatchewan North 0 0
South Zone 0 0
Calgary Zone 0 0
Central Zone 0 0
Edmonton Zone 0 0
North Zone 0 0
British Columbia Interior 0 0
British Columbia Fraser 0 0
British Columbia Vancouver Coastal 0 0
British Columbia Vancouver Island 0 0
British Columbia Northern 0 0
Yukon 0 0
Northwest Territories 0 0
Nunavut 0 0

Laboratory Summary

Measles

Genotyping is pending for 1 case.

For 2014, measles genotype information is available for 111 of 127 reported cases and the genotypes were: B3 (n=65), D8 (n=36), D9 (n=5), H1 (n=3), and D4 (n=2).

Figure 3: Distribution of measles genotypes detected in 2014 (n=111) by week of rash onset (if available, n=85) or specimen collection (n=26). Epidemiological weeks are assigned in accordance with WHO guidelines (WHO.WER.2012;9(87):73) with week 1 beginning on the first Monday of the year.

Figure 3

* Genotype B3 sequences identical to sequence variant MVi/Harare.ZWE/38.09 (GenBank accession number JF973033)

Genotype D8 sequences identical to sequence variant MVs/Taunton.GBR/27.12 (GenBank accession number JX984461)

Figure 3: Distribution of measles genotypes detected in 2014 by week of rash onset (if available) or specimen collection. Epidemiological weeks are assigned in accordance with WHO guidelines (WHO.WER.2012;9(87):73) with week 1 beginning on the first Monday of the year.
Epi week B3 B3 - Harare D4 D8 D8 - Taunton D9 H1 Total
1 0 1 0 0 0 0 0 1
2 0 5 0 0 0 0 0 5
3 0 7 0 0 0 0 0 7
4 0 3 0 0 0 0 0 3
5 0 3 0 0 0 0 0 3
6 0 1 0 0 0 0 0 1
7 0 0 0 0 0 0 0 0
8 0 2 0 0 0 0 0 2
9 1 2 0 0 3 0 0 6
10 0 1 0 0 6 0 0 7
11 1 1 0 0 7 0 0 9
12 2 5 0 0 7 0 0 14
13 1 0 0 1 5 0 0 7
14 2 2 1 0 1 4 0 10
15 0 4 0 0 0 1 1 6
16 1 3 1 1 4 0 1 11
17 1 0 0 0 1 0 0 2
18 1 1 0 0 0 0 0 2
19 0 0 0 0 0 0 0 0
20 0 5 0 0 0 0 0 5
21 0 3 0 0 0 0 0 3
22 0 1 0 0 0 0 0 1
23 0 1 0 0 0 0 0 1
24 0 1 0 0 0 0 0 1
25 0 1 0 0 0 0 0 1
26 0 0 0 0 0 0 0 0
27 0 0 0 0 0 0 0 0
28 0 0 0 0 0 0 0 0
29 0 0 0 0 0 0 0 0
30 0 0 0 0 0 0 1 1
31 0 1 0 0 0 0 0 1
32 0 0 0 0 0 0 0 0
33 0 0 0 0 0 0 0 0
34 0 1 0 0 0 0 0 1
35 0 0 0 0 0 0 0 0
36 0 0 0 0 0 0 0 0
37 0 0 0 0 0 0 0 0
38 0 0 0 0 0 0 0 0
39 0 0 0 0 0 0 0 0
40 0 0 0 0 0 0 0 0
41 0 0 0 0 0 0 0 0
42 0 0 0 0 0 0 0 0
43 0 0 0 0 0 0 0 0
44 0 0 0 0 0 0 0 0
45 0 0 0 0 0 0 0 0
46 0 0 0 0 0 0 0 0
47 0 0 0 0 0 0 0 0
48 0 0 0 0 0 0 0 0
49 0 0 0 0 0 0 0 0
50 0 0 0 0 0 0 0 0
51 0 0 0 0 0 0 0 0
52 0 0 0 0 0 0 0 0
53 0 0 0 0 0 0 0 0
Total 10 55 2 2 34 5 3 111


The current global distribution of measles genotypes can be found on the WHO Measles Nucleotide Surveillance (MeaNS) website.

For information regarding the interpretation and use of measles genotyping (including a discussion of genotypes and sequence variants), refer to Hiebert J and Severini A. Canada Communicable Disease Report. 2014; 40-12: 257- 260.

Footnotes

Date modified: